ArticleInternational journal of radiation biology2021

Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.

Meghna Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.